Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) was given a new $184.00 price target on by analysts at Royal Bank of Canada. They now have a "buy" rating on the stock.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com